Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021

SELL
$16.29 - $21.92 $223,726 - $301,049
-13,734 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$15.75 - $25.45 $216,310 - $349,530
13,734 New
13,734 $240,000
Q3 2020

Nov 06, 2020

SELL
$18.4 - $26.59 $317,988 - $459,528
-17,282 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$11.51 - $20.97 $198,915 - $362,403
17,282 New
17,282 $336,000

Others Institutions Holding MIRM

About Mirum Pharmaceuticals, Inc.


  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.7B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.